NDC 71288-143
Docetaxel anhydrous
Docetaxel Anhydrous
Docetaxel anhydrous is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc. The primary component is Docetaxel Anhydrous.
| Product ID | 71288-143_bde535be-817f-4e14-e053-2a95a90a7b4f |
| NDC | 71288-143 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Docetaxel anhydrous |
| Generic Name | Docetaxel Anhydrous |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-08-24 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209634 |
| Labeler Name | Meitheal Pharmaceuticals Inc |
| Substance Name | DOCETAXEL ANHYDROUS |
| Active Ingredient Strength | 20 mg/2mL |
| Pharm Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |